ANJI PHARMA Trademark

Trademark Overview

On Wednesday, August 5, 2020, a trademark application was filed for ANJI PHARMA with the United States Patent and Trademark Office. The USPTO has given the ANJI PHARMA trademark a serial number of 90094836. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 1, 2024. This trademark is owned by Anji Pharmaceuticals Inc.. The ANJI PHARMA trademark is filed in the Pharmaceutical Products category with the following description:

House mark for pharmaceutical preparations; pharmaceutical preparations for human use for treatment and prevention of inflammatory, oncological, autoimmune, genetic, neurological, metabolic, infectious, hematological, musculo-skeletal, degenerative, cardiovascular, respiratory, gastrointestinal, endocrinological, dermatological, genitourinary, ophthalmological, hepatic, and nephrological diseases and conditions; pharmaceutical preparations for human use for treatment and prevention of pain; pharmaceutical preparations for human use for treatment and prevention of allergies
anji pharma

General Information

Serial Number90094836
Word MarkANJI PHARMA
Filing DateWednesday, August 5, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 6, 2021

Trademark Statements

Goods and ServicesHouse mark for pharmaceutical preparations; pharmaceutical preparations for human use for treatment and prevention of inflammatory, oncological, autoimmune, genetic, neurological, metabolic, infectious, hematological, musculo-skeletal, degenerative, cardiovascular, respiratory, gastrointestinal, endocrinological, dermatological, genitourinary, ophthalmological, hepatic, and nephrological diseases and conditions; pharmaceutical preparations for human use for treatment and prevention of pain; pharmaceutical preparations for human use for treatment and prevention of allergies
NOT AVAILABLE"PHARMA"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 3, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAnji Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameAnji Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02143

Trademark Events

Event DateEvent Description
Saturday, August 8, 2020NEW APPLICATION ENTERED
Thursday, September 3, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 30, 2020ASSIGNED TO EXAMINER
Tuesday, December 1, 2020NON-FINAL ACTION WRITTEN
Tuesday, December 1, 2020NON-FINAL ACTION E-MAILED
Tuesday, December 1, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 26, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 26, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 26, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 28, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 16, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 6, 2021PUBLISHED FOR OPPOSITION
Tuesday, July 6, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 31, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, February 11, 2022SOU TEAS EXTENSION RECEIVED
Friday, February 11, 2022SOU EXTENSION 1 FILED
Friday, February 11, 2022SOU EXTENSION 1 GRANTED
Tuesday, February 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 15, 2022SOU TEAS EXTENSION RECEIVED
Monday, August 15, 2022SOU EXTENSION 2 FILED
Monday, August 15, 2022SOU EXTENSION 2 GRANTED
Wednesday, August 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 7, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, February 7, 2023SOU EXTENSION 3 FILED
Tuesday, February 7, 2023SOU EXTENSION 3 GRANTED
Thursday, February 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 30, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 30, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 30, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 30, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, August 3, 2023SOU EXTENSION 4 FILED
Thursday, August 3, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 3, 2023SOU EXTENSION 4 GRANTED
Saturday, August 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 1, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, April 1, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

pharma anji preparations pharmaceutical prevention human treatment dermatological genitourinary endocrinological gastrointestinal respiratory